Literature DB >> 12767542

Homogenous distribution of fast response action potentials in canine pulmonary vein sleeves: a contradictory report.

Tsui-min Wang1, Chern-en Chiang, Joen-ron Sheu, Chi-hsiang Tsou, Hsiu-ming Chang, Hsiang-ning Luk.   

Abstract

Pulmonary veins may serve as source of ectopic focus (or foci) in initiating atrial tachyarrhythmias in human beings. However, the animal model for such focal atrial fibrillation is still lacking and cellular mechanism for arrhythmias remains to be studied. Recently, a series of reports of cellular electrophysiological characterization of pulmonary vein sleeves demonstrated an extremely high incidence of automaticity (varied from 40 to 76%) and triggered activity (from 0 to 44%) in normal healthy control dogs and rabbits. The present study was therefore designed to re-investigate the cellular electrophysiological properties of canine pulmonary veins. Intracellular action potentials were characterized in pulmonary vein sleeves in 50 normal healthy dogs. Conventional glass microelectrode recording technique was used. Experiments were focused on the incidence of automaticity and triggered activity in pulmonary vein sleeve tissues. Surprisingly, our results showed that all pulmonary vein sleeves tissues in these dogs displayed fast-response action potentials under the well-controlled experimental condition (100%, n=50). No spontaneous pacemaking activities, early or delayed afterdepolarisations were observed (0%, n=50). No high-frequency spikes or irregular rhythm could be recorded in all experiments (0%, n=50). Both the frequency response and membrane responsiveness of the pulmonary vein action potentials were characterized. No electrophysiological inhomogeneity between the distal and the proximal part of the sleeves was observed. In conclusion, canine pulmonary vein sleeves do not display arrhythmogenic activities under normal physiological conditions. The possible explanations for the controversy in pulmonary veins electrophysiology were discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12767542     DOI: 10.1016/s0167-5273(02)00474-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

Review 2.  Triggered activity and atrial fibrillation.

Authors:  Andrew L Wit; Penelope A Boyden
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

Review 3.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  Ectopic activity in the rat pulmonary vein can arise from simultaneous activation of alpha1- and beta1-adrenoceptors.

Authors:  V Maupoil; C Bronquard; J-L Freslon; P Cosnay; I Findlay
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

5.  Discontinuous thoracic venous cardiomyocytes and heart exhibit synchronized developmental switch of troponin isoforms.

Authors:  Martin P Kracklauer; Han-Zhong Feng; Wenrui Jiang; Jenny L-C Lin; Jim J-C Lin; Jian-Ping Jin
Journal:  FEBS J       Date:  2013-01-02       Impact factor: 5.542

6.  Profibrillatory Structural and Functional Properties of the Atrial-Pulmonary Junction in the Absence of Remodeling.

Authors:  Lisa A Gottlieb; Charly Belterman; Shirley van Amersfoorth; Virginie Loyer; Marion Constantin; Mélèze Hocini; Lukas R C Dekker; Ruben Coronel
Journal:  Front Physiol       Date:  2021-11-24       Impact factor: 4.566

7.  Hyperpolarization activated cation current (I(f)) in cardiac myocytes from pulmonary vein sleeves in the canine with atrial fibrillation.

Authors:  Jia-Yue Li; Hong-Juan Wang; Bin Xu; Xue-Ping Wang; Yi-Cheng Fu; Mei-Yan Chen; De-Xian Zhang; Yan Liu; Qiao Xue; Yang Li
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.